The glycosphingolipid GD2 as an effective but enigmatic target of passive immunotherapy in children with aggressive neuroblastoma (HR-NBL)
Rovigatti, UgoJournal:
Cancer Letters
DOI:
10.1016/j.canlet.2020.11.044
Date:
November, 2020
File:
PDF, 921 KB
2020